Related references
Note: Only part of the references are listed.Infantile hemangiomas β3-adrenoceptor overexpression is associated with nonresponse to propranolol
Andrea Bassi et al.
PEDIATRIC RESEARCH (2022)
Association between signs of hyperalgesia and reported frequent pain in jaw-face and head
Negin Yekkalam et al.
ACTA ODONTOLOGICA SCANDINAVICA (2021)
Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome
Shih-Pin Chen et al.
ANNALS OF NEUROLOGY (2021)
How does the brain change in chronic migraine? Developing disease biomarkers
Patricia Pozo-Rosich et al.
CEPHALALGIA (2021)
An outlook on the trigeminovascular mechanisms of action and side effects concerns of some potential neuropeptidergic antimigraine therapies
Abimael Gonzalez-Hernandez et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Migraine therapeutics differentially modulate the CGRP pathway
Minoti Bhakta et al.
CEPHALALGIA (2021)
Slowly repeated evoked pain (SREP) as a central sensitization marker in episodic migraine patients
Pablo de la Coba et al.
SCIENTIFIC REPORTS (2021)
Targets for migraine treatment: beyond calcitonin gene-related peptide
David Moreno-Ajona et al.
CURRENT OPINION IN NEUROLOGY (2021)
Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen
Robert P. Cowan et al.
HEADACHE (2021)
Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial
Samira Khani et al.
JOURNAL OF HEADACHE AND PAIN (2021)
Adrenergic inhibition facilitates normalization of extracellular potassium after cortical spreading depolarization
Hiromu Monai et al.
SCIENTIFIC REPORTS (2021)
Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries
Eloisa Rubio-Beltran et al.
CEPHALALGIA (2020)
Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study
Dawn C. Buse et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system
Alejandro Labastida-Ramirez et al.
PAIN (2020)
Monoaminergic Receptors as Modulators of the Perivascular Sympathetic and Sensory CGRPergic Outflows
Bruno A. Marichal-Cancino et al.
CURRENT NEUROPHARMACOLOGY (2020)
Ubrogepant: First Approval (vol 80, pg 323, 2020)
Lesley J. Scott
DRUGS (2020)
Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives
Eleonora De Matteis et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
Cervical Noninvasive Vagus Nerve Stimulation for Migraine and Cluster Headache: A Systematic Review and Meta-Analysis
Yin-Hsuan Lai et al.
NEUROMODULATION (2020)
Choroid plexus and the blood-cerebrospinal fluid barrier in disease
Peter Solar et al.
FLUIDS AND BARRIERS OF THE CNS (2020)
CGRP Plasma Levels Decrease in Classical Trigeminal Neuralgia Patients Treated with Botulinum Toxin Type A: A Pilot Study
Yi Zhang et al.
PAIN MEDICINE (2020)
Anti-migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice
Inge A. Mulder et al.
ANNALS OF NEUROLOGY (2020)
The locus of action of CGRPergic monoclonal antibodies against migraine: peripheral over central mechanisms
Abimael González-Hernández et al.
CNS & Neurological Disorders-Drug Targets (2020)
Acute sleep deprivation enhances susceptibility to the migraine substrate cortical spreading depolarization
Andrea Negro et al.
JOURNAL OF HEADACHE AND PAIN (2020)
The fifth cranial nerve in headaches
J. C. A. Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Modulation of mechanosensory vibrissal responses in the trigeminocervical complex by stimulation of the greater occipital nerve in a rat model of trigeminal neuropathic pain
Nuria Garcia-Magro et al.
JOURNAL OF HEADACHE AND PAIN (2020)
CGRP inhibitors for migraine prophylaxis: a safety review
Eduardo Rivera-Mancilla et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Cortical spreading depolarisation-induced facial hyperalgesia, photophobia and hypomotility are ameliorated by sumatriptan and olcegepant
Chunhua Tang et al.
SCIENTIFIC REPORTS (2020)
Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity
Patrick T. Ronaldson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity
Hossam Kadry et al.
FLUIDS AND BARRIERS OF THE CNS (2020)
Estrogen receptors α, β and GPER in the CNS and trigeminal system-molecular and functional aspects
Karin Warfvinge et al.
JOURNAL OF HEADACHE AND PAIN (2020)
The potential of lasmiditan in migraine
Jasper Mecklenburg et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Potential Mechanisms Involved in Palmitoylethanolamide-Induced Vasodepressor Effects in Rats
Bruno A. Marichal-Cancino et al.
JOURNAL OF VASCULAR RESEARCH (2020)
Targeting the central projection of the dural trigeminovascular system for migraine prophylaxis
Simon Akerman et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
Fremanezumab: First Global Approval (vol 78, pg 1829, 2018)
Sheridan M. Hoy
DRUGS (2019)
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Valentina Favoni et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Gepants for the treatment of migraine
Andrea Negro et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP's Role in Migraine with Aura
Aaron J. Schain et al.
JOURNAL OF NEUROSCIENCE (2019)
Erenumab in chronic migraine with medication overuse Subgroup analysis of a randomized trial
Stewart J. Tepper et al.
NEUROLOGY (2019)
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine
Messoud Ashina et al.
CEPHALALGIA (2019)
Altered Vascular Permeability in Migraine-associated Brain Regions: Evaluation with Dynamic Contrast-enhanced MRI
Yeon Soo Kim et al.
RADIOLOGY (2019)
Venlafaxine pharmacogenetics:a comprehensive review
Justyna Suwala et al.
PHARMACOGENOMICS (2019)
C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system
Jacob C. A. Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Propranolol prevents cerebral blood flow changes and pain-related behaviors in migraine model mice
Yuki Kurauchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Mechanisms of migraine as a chronic evolutive condition
Anna P. Andreou et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Recognizing the role of CGRP and CGRP receptors in migraine and its treatment
Lars Edvinsson et al.
CEPHALALGIA (2019)
Amitriptyline inhibits the MAPK/ERK and CREB pathways and proinflammatory cytokines through A3AR activation in rat neuropathic pain models
Yumi Kim et al.
KOREAN JOURNAL OF ANESTHESIOLOGY (2019)
Side effects associated with current and prospective antimigraine pharmacotherapies
Abimael Gonzalez-Hernandez et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Menstrual Migraine and Treatment Options: Review
Edward M. Lichten
HEADACHE (2018)
PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma
James A. Waschek et al.
JOURNAL OF HEADACHE AND PAIN (2018)
β-Adrenoceptor Blockade for Infantile Hemangioma Therapy: Do β3-Adrenoceptors Play a Role?
Carlos E. Escarcega Gonzalez et al.
JOURNAL OF VASCULAR RESEARCH (2018)
Targeted Orexin and Hypothalamic Neuropeptides for Migraine
Lauren C. Strother et al.
NEUROTHERAPEUTICS (2018)
Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action
Till Sprenger et al.
NEUROTHERAPEUTICS (2018)
Evaluation of Galcanezumab for the Prevention of Episodic Migraine The EVOLVE-1 Randomized Clinical Trial
Virginia L. Stauffer et al.
JAMA NEUROLOGY (2018)
Central and peripheral processes in headache
Adithya Varma et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2018)
A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline
Melanie Kremer et al.
JOURNAL OF NEUROSCIENCE (2018)
Hyponatremia and the Brain
Fabrice Gankam Kengne et al.
KIDNEY INTERNATIONAL REPORTS (2018)
Topiramate in Migraine Prevention: A 2016 Perspective
Stephen D. Silberstein
HEADACHE (2017)
Beta-1 vs. beta-2 adrenergic control of coronary blood flow during isometric handgrip exercise in humans
Stephan R. Maman et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine
Mohammad Al-Mahdi Al-Karagholi et al.
JOURNAL OF HEADACHE AND PAIN (2017)
The enigma of site of action of migraine preventives: no effect of metoprolol on trigeminal pain processing in patients and healthy controls
Julia M. Hebestreit et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody
Agustin Melo-Carrillo et al.
JOURNAL OF NEUROSCIENCE (2017)
The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments
Carlos M. Villalon et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Propranolol treatment prevents chronic central sensitization induced by repeated dural stimulation
Nelly Boyer et al.
PAIN (2017)
A method for determining when the superficial scalp arteries are the source of migraine pain
E. Shevel
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2017)
Revisiting atenolol as a low passive permeability marker
Xiaomei Chen et al.
FLUIDS AND BARRIERS OF THE CNS (2017)
The Journey of the Non-Vascular Relief for Migraine: From 'Triptans' To 'Ditans'
Alphienes S. Xavier et al.
CURRENT CLINICAL PHARMACOLOGY (2017)
Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats
V. H. Aviles-Rosas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura
Anders Hougaard et al.
BRAIN (2017)
Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches
Zdravko Lackovic et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Propranolol and Venlafaxine for Vestibular Migraine Prophylaxis: A Randomized Controlled Trial
Mehti Salviz et al.
LARYNGOSCOPE (2016)
Understanding migraine: Potential role of neurogenic inflammation
Rakesh Malhotra
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2016)
Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use
Thilinie Rajapakse et al.
HEADACHE (2016)
Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells
Lars Neeb et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Optimizing prophylactic treatment of migraine: Subtypes and patient matching
Michel Dib
Therapeutics and Clinical Risk Management (2016)
A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation
K. Hoehlig et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Inhibitory effect of chronic oral treatment with fluoxetine on capsaicin-induced external carotid vasodilatation in anaesthetised dogs
Enriqueta Munoz-Islas et al.
CEPHALALGIA (2015)
Migraine: Multiple Processes, Complex Pathophysiology
Rami Burstein et al.
JOURNAL OF NEUROSCIENCE (2015)
OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
Eva Cernuda-Morollon et al.
PAIN (2015)
The Blood-Brain Barrier
Richard Daneman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Vascular biomarkers in migraine
Gretchen E. Tietjen et al.
CEPHALALGIA (2015)
Arterial surgery for sporadic hemiplegic migraine: preliminary results
Elliot Shevel
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2014)
Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Lucy Sanchez-Covarrubias et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate
Charlotte Kageneck et al.
JOURNAL OF HEADACHE AND PAIN (2014)
Altered processing of sensory stimuli in patients with migraine
Marina de Tommaso et al.
NATURE REVIEWS NEUROLOGY (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Common hippocampal structural and functional changes in migraine
Nasim Maleki et al.
BRAIN STRUCTURE & FUNCTION (2013)
The missing link: Enhanced functional connectivity between amygdala and visceroceptive cortex in migraine
Nouchine Hadjikhani et al.
CEPHALALGIA (2013)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
Establishment of Neurovascular Congruency in the Mouse Whisker System by an Independent Patterning Mechanism
Won-Jong Oh et al.
NEURON (2013)
Migraine with Aura Is Associated with an Incomplete Circle of Willis: Results of a Prospective Observational Study
Brett Cucchiara et al.
PLOS ONE (2013)
Migraine is not primarily a vascular disorder
Andrew Charles
CEPHALALGIA (2012)
Migraine changes the brain: neuroimaging makes its mark
Till Sprenger et al.
CURRENT OPINION IN NEUROLOGY (2012)
Pharmacological evidence that spinal α2C- and, to a lesser extent, α2A-adrenoceptors inhibit capsaicin-induced vasodilatation in the canine external carotid circulation
Carlos M. Villalon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors
Bruno A. Marichal-Cancino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan - Basic Science in Relation to Migraine Treatment
Carl Dahlof et al.
HEADACHE (2012)
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
Tony W. Ho et al.
HEADACHE (2012)
Beta-blocker migraine prophylaxis affects the excitability of the visual cortex as revealed by transcranial magnetic stimulation
Marcus Gerwig et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. Holland et al.
NEUROLOGY (2012)
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression
Alessandro Tozzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine
Caterina Mainero et al.
ANNALS OF NEUROLOGY (2011)
The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men
Bart J. Van der Schueren et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Anatomical Variants of the Circle of Willis and Brain Lesions in Migraineurs
C. Cavestro et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2011)
Pathophysiology of medication overuse headache: Insights and hypotheses from preclinical studies
Ian D. Meng et al.
CEPHALALGIA (2011)
Protection of flunarizine on cerebral mitochondria injury induced by cortical spreading depression under hypoxic conditions
Fengpeng Li et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization?
Dimos D. Mitsikostas et al.
JOURNAL OF HEADACHE AND PAIN (2011)
The extracranial vascular theory of migraine: an artificial controversy
Elliot Shevel
JOURNAL OF NEURAL TRANSMISSION (2011)
Migraine preventive drugs differentially affect cortical spreading depression in rat
Volodymyr Borysovych Bogdanov et al.
NEUROBIOLOGY OF DISEASE (2011)
Brain Morphological Signatures for Chronic Pain
Marwan N. Baliki et al.
PLOS ONE (2011)
Potential mechanisms of prospective antimigraine drugs: A focus on vascular (side) effects
Kayi Y. Chan et al.
PHARMACOLOGY & THERAPEUTICS (2011)
An update on the blood vessel in migraine
K. C. Brennan et al.
CURRENT OPINION IN NEUROLOGY (2010)
Topiramate Versus Amitriptyline in Migraine Prevention: A 26-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Noninferiority Trial in Adult Migraineurs
David W. Dodick et al.
CLINICAL THERAPEUTICS (2009)
Spinal sumatriptan inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors
Enriqueta Munoz-Islas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Prophylactic Drugs and Cytokine and Leptin Levels in Children With Migraine
Tugba Hirfanoglu et al.
PEDIATRIC NEUROLOGY (2009)
Proinflammatory Plasma Cytokines in Children With Migraine
Leszek Bockowski et al.
PEDIATRIC NEUROLOGY (2009)
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Carlos M. Villalon et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Review: Menstrual migraine: therapeutic approaches
E. Anne MacGregor
Therapeutic Advances in Neurological Disorders (2009)
Migraine and circle of Willis anomalies
Brett Cucchiara et al.
MEDICAL HYPOTHESES (2008)
Peripheral mechanism of action of antimigraine prophylactic drugs
Fabio Frediani et al.
NEUROLOGICAL SCIENCES (2008)
Central mechanism of action of antimigraine prophylactic drugs
Gerardo Casucci et al.
NEUROLOGICAL SCIENCES (2008)
The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache
Jes Olesen
PHARMACOLOGY & THERAPEUTICS (2008)
Effect of two novel CGRP-binding compounds in a closed cranial window rat model
Louise Juhl et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
P. K. Gillman
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Phosphorylation of sodium channels mediated by protein kinase-C modulates inhibition by topiramate of tetrodotoxin-sensitive transient sodium current
G. Curia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
The structure and mode of action of different botulinum toxins
J. O. Dolly et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine
S. Gupta et al.
CEPHALALGIA (2006)
Suppression of cortical spreading depression in migraine prophylaxis
C Ayata et al.
ANNALS OF NEUROLOGY (2006)
Perivascular nerves and the regulation of cerebrovascular tone
E Hamel
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Neurogenic inflammation and migraine: Implications for therapeutics
SJ Peroutka
MOLECULAR INTERVENTIONS (2005)
Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat - a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage
F Richter et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study
MC Kruit et al.
BRAIN (2005)
Topiramate inhibits trigeminovascular activation: an intravital microscopy study
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Topiramate inhibits the initiation of plateau potentials in CA1 neurons by depressing R-type calcium channels
JB Kuzmiski et al.
EPILEPSIA (2005)
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers
KA Petersen et al.
CEPHALALGIA (2005)
The efficacy and safety of venlafaxine in the prophylaxis of migraine
SN Ozyalcin et al.
HEADACHE (2005)
Cortical hyperexcitability in migraine patients before and after sodium valproate treatment
SM Bowyer et al.
JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2005)
Cortical spreading depression produces long-term disruption of activity-related changes in cerebral blood volume and neurovascular coupling
M Guiou et al.
JOURNAL OF BIOMEDICAL OPTICS (2005)
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
KG Shields et al.
BRAIN (2005)
Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT1B/1D receptor agonists
D Levy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study
S Bulut et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2004)
Analgesic triptan action in an animal model of intracranial pain: A race against the development of central sensitization
R Burstein et al.
ANNALS OF NEUROLOGY (2004)
Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs
K Kapoor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Divalproex sodium extended-release for the prophylaxis of migraine headache
FG Freitag
EXPERT OPINION ON PHARMACOTHERAPY (2003)
Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynarnic responses in the pig
K Kapoor et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
2003 Wolff Award: Possible parasympathetic contributions to peripheral and central sensitization during migraine
D Yarnitsky et al.
HEADACHE (2003)
Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein
DC Evans et al.
DRUG METABOLISM AND DISPOSITION (2003)
Regulation of glutamatergic neurotransmission in the striatum by presynaptic adenylyl cyclase-dependent processes
R Dohovics et al.
NEUROCHEMISTRY INTERNATIONAL (2003)
Calcitonin receptor-like receptor: identification and distribution in human peripheral tissues
S Hagner et al.
CELL AND TISSUE RESEARCH (2002)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
Triptans reduce the inflammatory response in bacterial meningitis
O Hoffmann et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Acute migraine headache - Possible sensitization of neurons in the spinal trigeminal nucleus?
H Kaube et al.
NEUROLOGY (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Two new actions of topiramate:: inhibition of depolarizing GABAA-mediated responses and activation of a potassium conductance
AI Herrero et al.
NEUROPHARMACOLOGY (2002)
Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT1B and 5-HT1D receptor antagonists and in situ hybridization
RWM van den Broek et al.
CEPHALALGIA (2002)
The anti-migraine 5-HT1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs
DJ Williamson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Mechanism of migraine and action of antimigraine medications
ELH Spierings
MEDICAL CLINICS OF NORTH AMERICA (2001)
Neurogenic inflammation in the context of migraine
DJ Williamson et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2001)
Nitric oxide-induced headache in patients with chronic tension-type headache
M Ashina et al.
BRAIN (2000)
Mechanisms of action of valproate: a commentatory
CU Johannessen
NEUROCHEMISTRY INTERNATIONAL (2000)
Botulinum toxin type A as a migraine preventive treatment
S Silberstein et al.
HEADACHE (2000)
Share Paper
